| Sample | Title | Value | Rank |
|---|
| GSM132917 | SKI-DLCL cells_untreated_24h_1rpt | 1 | 7 |
| GSM132918 | SKI-DLCL cells_untreated_24h_2rpt | 7.3 | 32 |
| GSM132920 | SKI-DLCL cells_untreated_24h_rpt3 | 5.6 | 30 |
| GSM132941 | SKI-DLCL cells_Aplidin 3nM_24h_rpt1 | 2.9 | 19 |
| GSM132944 | SKI-DLCL cells_Aplidin 3.0nM_24h_rpt2 | 12.3 | 37 |
| GSM132947 | SKI-DLCL cells_Aplidin treated 3nM_24h_rpt3 | 12.4 | 40 |
| GSM132949 | SKI-DLCL cells_AraC 20nM_24h_rpt1 | 5.1 | 26 |
| GSM132950 | SKI-DLCL cells_AraC 20nM_24h_rpt2 | 1 | 7 |
| GSM132953 | SKI-DLCL cells_AraC 20nM_24h_rpt3 | 5 | 27 |
| GSM132955 | SKI-DLCL cells_Aplidin 1.5nM AraC 5nM_24h_rpt1 | 2.2 | 17 |
| GSM132956 | SKI-DLCL cells_Aplidin 1.5 nM AraC 5nM_24h_rpt2 | 3.1 | 21 |
| GSM132960 | SKI-DLCL cells_Aplidin 1.5 nM AraC 5.0 nM_24h_rpt3 | 11.8 | 39 |
| GSM132760 | SKI-DLCL_tumor_untreated animals | 13.7 | 31 |
| GSM132916 | SKI-DLCL_tumor_animals treated with 1mg/kg Aplidin_50mg/kg AraC | 7.4 | 22 |